Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy

Mubin Tarannum1, Rizwan Romee1, Roman M Shapiro1

  • 1Division of Stem Cell Transplant and Cellular Therapy, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.

Related Concept Videos